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Abstract
Objectives: It is to describe an immunocompetent adult patient with hepatitis and Guillain-Barré syndrome (GBS)
after Cytomegalovirus (CMV) infection. In the initial course of the diagnosis and treatment, CMV infection was
ignored.
Case report: A 19-year-old Chinese girl complained of fatigue with pain and numbness of the limbs, with
abnormal liver function. She was diagnosed as a case of GBS based on history, clinical findings and auxiliary
examinations. On day 13 of admission, her liver function was still abnormal. So CMV was recommended to
examine. CMV hepatitis was diagnosed on positive serum anti-CMV IgG and IgM antibodies. The case was
improved only with intravenous immunoglobulin therapy, without the use of antiviral therapy.
Conclusions: This case showed an immunocompetent adult patient with hepatitis and GBS induced by CMV. The
physicians should take into account multi-system involvement of severe CMV infection.
Introduction
Cytomegalovirus (CMV) belongs to the herpes virus
family, DNA virus. CMV infection is most commonly
sub clinical. In the immunocompromised host, primary
CMV infection, reactivation and re-infection are all
associated with significant morbidity and mortality [1,2].
In the immunocompetent adult, primary CMV infection
is usually asymptomatic but can result in a mononucleo-
sis syndrome [1-3]. CMV infection in immunocompe-
tent hosts may rarely be able to lead to severe organ
specific complications. But some serious complications
have been reported. Severe hepatitis is a frequent pre-
sentation [4,5]. Central nervous system disorders consti-
tuted the second most frequent manifestations of CMV
infection in immunocompetent patients, mainly as
meningitis, encephalitis, myelitis, nerve palsies, Guillain-
Barré syndrome (GBS), et al. [2,6-9] But the cases
involved the liver and central nervous system are very
r a r e .W ed e s c r i b e dt h ef i r s tc a s er e p o r t e di nC h i n a ,o f
CMV induced hepatitis and GBS in an immunocompe-
tent adult patient.
Case report
A 19-year-old Chinese girl was admitted to local hospi-
tal complaining of fatigue with pain and numbness of
the limbs after the onset of an upper respiratory tract
infection 10 days ago. Laboratory test showed alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) had been significantly elevated, but negative
hepatitis virus. And the patient had no drug history.
Hepatitis was diagnosed, and the patient received corre-
sponding therapies, but the symptoms did not improve.
And the patient accompanied by limb weakness and
trismus 5 days before admission to Neurology Depart-
ment of our hospital.
Upon physical examination after admission: the
patient’s blood pressure was 120/85 mmHg, respiratory
rate 16 breaths per minute, heart rate 68 beats per min-
ute, and temperature 36.8°Celsius. No obvious skin and
sclera jaundice. On neurological examination, the
patient was conscious and speech fluent, and her orien-
tation, calculation, memory, attention and understanding
were normal. Bilateral mild peripheral facial nerve palsy
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frown poor on the right, bilateral nasolabial slightly
shallow, teeth show little effort, but drum gills normal.
All other cranial nerves were intact. Motor strength of
the limbs was grade 3. Muscle stone of the limbs
decreased. There was obviously grip pain on bilateral
forearm and gastrocnemius muscles. Distal limbs were
allergic to pain perception. Deep tendon reflexes on the
upper limbs were diminished and absent on the lower
limbs. No pathological reflexes were elicited. Finger
refers to the nose was accurate.
Auxiliary examination of the first day of admission:
Electromyography (ECG): Motor nerve conduction velo-
city of bilateral median nerve and peroneal nerve was
normal, but the distal latency; evoked potential ampli-
tude of double the median nerve and right peroneal
nerve reduced. Liver, gallbladder and spleen ultrasono-
graphy were normal. Lumbar puncture: pressure mea-
sured 100 mmH2O, and a spinal tap yielded clear,
colorless cerebrospinal fluid (CSF) with the following
component levels: glucose 2.89 mmol/L, protein 0.8 g/L,
and chloride 121.0 mmol/L. Gram staining, ink staining
and anti-acid staining were negative. On cytospin pre-
parations, 7 cells were collected. CSF findings indicated
cells-protein separation. Arterial oxygen pressure and
saturation were normal. Complete blood count and
chemistry levels were normal, except for ALT and AST
levels of 303.8 U/L and 106.3 U/L respectively, indicat-
ing acute or chronic liver injury. But the patient had no
history of liver insufficiency, and all of hepatitis virus
test were negative (including A, B, C, D and E).
The patient was diagnosed as a case of GBS based on
history, clinical findings and auxiliary examinations
(ECG and CSF) [10]. So intravenous immunoglobulin
therapy (20 g/day for five days) and intramuscular injec-
tion of vitamin B1 and B12 were instituted. However,
impaired liver function was concerned since there were
no significant clinical findings of liver (negative hepatitis
virus and unremarkable liver ultrasonography).
On her second hospital day, the whole body pain got
slightly improved. 5 days after admission, her whole body
pain significantly improved and she could walk alone
(Motor strength of the limbs grade 3+). But the symp-
toms of the right peripheral facial paralysis were more
severe than the left. Liver function examined again ALT
and AST levels of 172 U/L and 69 U/L respectively.
On day 13, the patient could go downstairs (Motor
strength of the limbs grade 4). Liver function examined
again ALT and AST levels of 147 U/L and 87 U/L
respectively, indicating liver function was still abnormal.
Department of Gastroenterology and Infectious Disease
were invited to consult this patient. CMV infection was
concerned. Positive serum anti-CMV IgG antibody (10.4
IU/mL) and IgM antibody (59.2 IU/mL) were found
serially using commercially available ELISA kit. CMV-
D N Ab yP C Ri nb l o o da n du r i n ew e r en e g a t i v e .T h u s ,
CMV infection combined with CMV liver injury was
diagnosed prompted on the patient’s liver enzyme test
and positive serum anti-CMV IgG and IgM antibodies.
For CMV-DNA negative, antiretroviral therapy didn’tb e
used, only protection of liver function was administered.
By day 19, the patient gradually recovered from the
limbs weakness and facial paralysis and was discharged.
A month follow-up tests indicated the patient was fully
recovered, showing negative CMV-DNA in blood and
urine and liver function normal. On neurological exami-
nation, the patient was fully recovered clinically includ-
ing facial nerve normal, muscle strength and stone
normal, and deep tendon reflexes normal.
Discussion
Manifestations of CMV infection in immunocompro-
mised hosts have been extensively reported, but those
observed in immunocompetent patients have received
comparatively little attention. Clinical manifestations of
CMV infection include fever, pancytopenia, hepatitis,
rarely colitis, pneumonia and retinitis [1,2]. Neurological
involvement by CMV (such as GBS) is usually attributed
to aberrant immunological responses triggered by the
presence of CMV, but not due to direct infection [11].
Intensive care management with ventilatory support and
the use of intravenous immunoglobulin have significantly
improved outcomes in GBS patients [12]. The improve-
ment observed in some of the treated patients of CMV
may have been related to the typically self-limiting course
of the disease, so no conclusive statements regarding the
use of antiviral treatment can be made from the available
data in the literature [2]. We described an immunocom-
petent adult patient with hepatitis and GBS induced by
CMV. In diagnosis and treatment of this case, we initially
ignored the CMV infection. The case was improved only
with intravenous immunoglobulin therapy, without the
use of antiviral therapy for negative CMV-DNA. The les-
sons of diagnosis and treatment of this case alerted clini-
cians that multi-system involvement should be taken into
account severe CMV infection. Early recognition, assis-
tant examination as soon as possible and prompt treat-
ment is critical to improve overall outcomes.
Conclusion
This case showed an immunocompetent adult patient
with hepatitis and GBS induced by CMV. The physi-
cians should take into account multi-system involve-
ment of severe CMV infection.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
Ma et al. Virology Journal 2011, 8:95
http://www.virologyj.com/content/8/1/95
Page 2 of 3consent is available for review by the Editor-in-Chief of
this journal.
Acknowledgements
The authors are thankful to the other physicians and nursing staff who
participated in the care of this patient. This study was supported by
Shenyang Science and Technology Program No. F10-205-1-10.
Author details
1Department of Neurology, Shengjing Hospital of China Medical University,
Shenyang 110817, PR China.
2Virus Laboratory, Shengjing Hospital of China
Medical University, Shenyang 110817, PR China.
3Department of Infectious
Disease, Shengjing Hospital Affiliated to China Medical University, Shenyang
110817, PR China.
Authors’ contributions
YM, JF, YQ and XGD carried out the clinical examination and treatment of
the patient. YM and JF participated in the drafting of the manuscript,
literature search, and coordination. All authors read and approved the final
manuscript.
Competing interests
The authors hereby disclose any financial or personal relationship with other
people or organizations that could have inappropriately influenced this
work.
Received: 14 January 2011 Accepted: 4 March 2011
Published: 4 March 2011
References
1. Vancíková Z, Dvorák P: Cytomegalovirus infection in immunocompetent
and immunocompromised individuals–a review. Curr Drug Targets
Immune Endocr Metabol Disord 2001, 1:179-87.
2. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME: Severe
cytomegalovirus infection in apparently immunocompetent patients: a
systematic review. Virol J 2008, 5:47.
3. Giroud O, Meier P, San Millán D, Praz G: Severe CMV infection: not only in
immunocompromised patients. Rev Med Suisse 2010, 6:1918-21.
4. Azad AK, Ahmed T, Chowdhury AJ, Rahim MA, et al: Cytomegalovirus
induced hepatitis in an immunocompetent host. Mymensingh Med J 2008,
17(2 Suppl):S104-6.
5. Rahman S, Khan M: Acute cytomegalovirus hepatitis in
immunocompetent host. Kathmandu Univ Med J (KUMJ) 2009, 7:79-81.
6. Devetag FC, Boscariolo L: Cytomegalovirus meningoencephalitis with
paroxysmal course in immunocompetent adults: a new nosographical
entity. Clinical, diagnostic and therapeutic correlations, and
pathogenetic hypothesis. Eur Neurol 2000, 44:242-7.
7. Eddleston M, Peacock S, Juniper M, Warrell DA: Severe cytomegalovirus
infection in immunocompetent patients. Clin Infect Dis 1997, 24:52-6.
8. Cohen JI, Corey GR: Cytomegalovirus infection in the normal host.
Medicine (Baltimore) 1985, 64:100-14.
9. Murakami N, Tomita Y, Koga M, Takahashi E, et al: An adolescent with
pharyngeal-cervical-brachial variant of Guillain-Barré syndrome after
cytomegalovirus infection. Brain Dev 2006, 28:269-71.
10. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for
Guillain-Barre syndrome. Ann Neurol 1990, 27(Suppl):S21-4.
11. Hughes RA, Cornblath DR: Guillain-Barre syndrome. Lancet 2005,
366:1653-66.
12. van der Meche FG, Schmitz PI: A randomized trial comparing intravenous
immune globulin and plasma exchange in Guillain-Barre syndrome.
Dutch Guillain-Barre Study Group. N Engl J Med 1992, 326:1123-9.
doi:10.1186/1743-422X-8-95
Cite this article as: Ma et al.: An immunocompetent adult patient with
hepatitis and guillain-barré syndrome after cytomegalovirus infection.
Virology Journal 2011 8:95.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ma et al. Virology Journal 2011, 8:95
http://www.virologyj.com/content/8/1/95
Page 3 of 3